Atopic Dermatitis Market is set to hit US$ 25.00 billion growing at CAGR of 15.0% from forecast period 2024 to 2032 | PMR

𝐀𝐭𝐨𝐩𝐢𝐜 𝐃𝐞𝐫𝐦𝐚𝐭𝐢𝐭𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐭𝐡𝐞 𝐚𝐭𝐨𝐩𝐢𝐜 𝐝𝐞𝐫𝐦𝐚𝐭𝐢𝐭𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟕.𝟏𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟐𝟓.𝟎𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟓.𝟎% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

Atopic dermatitis is an inflammation that leads to dry, itchy, or inflamed skin. It usually starts in childhood and can come and go or may affect individuals their entire lives. It looks like red rashes in people who have light-colored skin. Individuals who have dark skin may get gray, purple, or brown rashes. It's common for atopic dermatitis to develop in areas where the blending and flexing of the skin takes place.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size/request-for-sample

But it can also occur in other places, such as hands and fingers, feet and toes, arms, legs, lips, and eyelids. When diagnosing the condition, the healthcare provider will examine the skin and review the individual's medical and family history. In some cases, the individual may be asked to go through a skin or blood test.
The are various medications and treatments that can help manage the symptoms of atopic dermatitis. They include topical steroid creams, oral steroids, dupilumab, and antibiotics. Besides, wet dressings and light therapy may be used. With the introduction of cutting-edge technology and novel techniques, the atopic dermatitis market demand is projected to rise. Besides, rising funding and government support for R&D initiatives are anticipated to support the expansion of the market.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

• Toyo Tanso Co. Ltd.
• Tokai Carbon Co. Ltd.
• HEG Limited
• Graphite India Limited
• Graftech International Ltd.
• Mersen Group
• SGL Group
• Energizer Resources Inc.
• Focus Graphite Inc.
• Mason Graphite Inc.
• Hexagon Resources Limited
• Triton Minerals Ltd

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/Homecontroller/buyReport

𝐁𝐲 𝐃𝐫𝐮𝐠 𝐭𝐲𝐩𝐞 :
• Anti-Inflammatory agents
• Antihistamines
• Immunosuppressant
• Interleukin Inhibitors
• Topical Phosphodiesterase (PDE-4)
• Antiviral Agents
• Antibiotics
𝐁𝐲 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐚𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 :
• Oral
• Injectable
• Topical

𝐊𝐞𝐲 𝐒𝐭𝐚𝐭𝐬
• The market for atopic dermatitis was valued at USD 7.11 billion in 2023 and is projected to reach USD 25.00 billion by 2032.
• The market is projected to exhibit a compound annual growth rate (CAGR) of 15.0% during the forecast period of 2024 to 2032.
• The market demand in North America is anticipated to witness significant growth owing to the rising number of patients suffering from various skin conditions.
• Asia Pacific is projected to grow at the fastest rate in the atopic dermatitis market owing to the presence of quickly evolving healthcare technology.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐭𝐚𝐢𝐥𝐬 : https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size

𝐀𝐭𝐨𝐩𝐢𝐜 𝐃𝐞𝐫𝐦𝐚𝐭𝐢𝐭𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 :
• The injectable segment dominated the market due to the increased in the use of parenteral drugs via injections.
• Hospital segment having dominance in atopic dermatitis market over the forecast period because increases the number of atopic dermatitis cases and rise in the price of medication.
• The largest market in 2022 was North America, which is predicted to continue to rule the US market. In 2022, About 90% of the need for atopic dermatitis treatments in North America was anticipated to come from the United States. For instance, according to data from the Allergy & Asthma Network, over 91% of patients in the United States itch every day, and 15.5% of teenagers with AD express suicidal thoughts, compared to 9.1% of adolescents overall.
• Some of the major players operating in the global market include Galderma, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Bausch Health, Bayer AG, Encore Dermatology, Inc., AstraZeneca, Sanofi, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Mylan N.V.,

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 :

Cell Isolation/Cell Separation Market : https://www.polarismarketresearch.com/industry-analysis/global-cell-isolation-cell-separation-market
Patient Handling Equipment Market : https://www.polarismarketresearch.com/industry-analysis/patient-handling-equipment-market
IoT Medical Devices Market : https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
Respiratory Care Devices Market : https://www.polarismarketresearch.com/industry-analysis/respiratory-care-devices-market
Pharmaceutical Excipients Market : https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.